Tuesday, March 22, 2011
Netilmicin
It is an aminoglycoside antibiotic.It is derived from sisomycin and is similar in action to gentamicin.
Framycetin
It is an aminoglycoside and is a component of neomycin.
Mechanism of Action:
It binds to 30S subunit proteins and 16S rRNA resulting in the production of nonfunctional peptides.
Uses:It is used for the treatment of bacterial blepharitis and corneal injuries. It is also used for the treatment of Conjunctivitis.
Mechanism of Action:
It binds to 30S subunit proteins and 16S rRNA resulting in the production of nonfunctional peptides.
Uses:It is used for the treatment of bacterial blepharitis and corneal injuries. It is also used for the treatment of Conjunctivitis.
Dibekacin
It is an aminoglycoside antibiotic.It is derived from Kanamycin B.
Uses:
It is used in the infections of E. coli and P. Aeruginosa.
Uses:
It is used in the infections of E. coli and P. Aeruginosa.
Amikacin
It is an aminoglycoside antibiotic derived from Kanamycin A.
Action:
It binds to 30S ribosome of susceptible organism resulting in the inhibition of bacterial protein synthesis.
Uses:
It is used for the treatment of severe infections caused by Gram Negative Organisms including E. coli and Pseudomonas species.
Action:
It binds to 30S ribosome of susceptible organism resulting in the inhibition of bacterial protein synthesis.
Uses:
It is used for the treatment of severe infections caused by Gram Negative Organisms including E. coli and Pseudomonas species.
Verdamicin
It is an aminoglycoside derived from "Micromonospora" bacteria.
It is similar to gentamicin.
It is similar to gentamicin.
Subscribe to:
Comments (Atom)
-
Q: What do you know about ergot alkaloids? Ans: These include alkaloids which we get from the ergot fungus Claviceps purpurea or derived ...
-
It is the loss of water from a crystal. It means “to flower out” in French. It is the spontaneous loss of water (or solvent) from a hyd...
-
(For detailed study of Pharmaceutical Incompatibility Click here) Multiple Choice Questions (MCQs) from Pharmaceutical Incompatibility in ...